Miyagi, Japan

Kazuhiro Aoyagi

This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuhiro Aoyagi. Retrieved from https://idiyas.com/inventor/kazuhiro-aoyagi-tw52mrta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kazuhiro Aoyagi: Innovator in Transdermal Drug Delivery

Introduction

Kazuhiro Aoyagi is a notable inventor based in Miyagi, Japan. He has made significant contributions to the field of drug delivery systems, particularly through his innovative formulations that enhance the effectiveness of medications.

Latest Patents

Aoyagi holds a patent for "Formulations of propranolol and analogs as an amorphous melt or ionic liquid for transdermal drug delivery." This patent describes melts or ionic liquids containing amorphous propranolol, which can be used in topical formulations and patches for transdermal drug delivery. The formulations are designed to deliver a therapeutically effective amount of amorphous propranolol to patients, particularly for the treatment of infantile hemangioma. Notably, these formulations exhibit low viscosity and reduced skin irritation compared to the crystalline propranolol free base. The melts or ionic liquids can be created through a salt metathesis reaction.

Career Highlights

Aoyagi is affiliated with the University of California, where he continues to advance research in drug delivery technologies. His work has the potential to significantly improve patient outcomes through more effective and less irritating drug delivery methods.

Collaborations

Some of Aoyagi's notable coworkers include Michael Zakrewsky and Samir M Mitragotri, who have collaborated with him on various research projects.

Conclusion

Kazuhiro Aoyagi's innovative work in transdermal drug delivery exemplifies the impact of scientific research on healthcare. His contributions are paving the way for more effective treatments and improved patient experiences.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…